TY  - CHAP
M1  - Book, Section
TI  - Drug-Induced Liver Disease
A1  - Maddrey, Willis C.
A2  - Greenberger, Norton J.
A2  - Blumberg, Richard S.
A2  - Burakoff, Robert
PY  - 2016
T2  - CURRENT Diagnosis & Treatment: Gastroenterology, Hepatology, & Endoscopy, 3e
AB  - Clinically  apparent  liver  injury  from  a  Food  and  Drug  Administration  (FDA)-approved  drug  is  a  rare  event.  However  a  clinician  is  often  asked  to  provide  an  opinion  as  to  whether  elevations  in  liver  biochemical  studies  (especially  elevations  of  aminotransferases,  bilirubin,  or  alkaline  phosphatase)  may  have  been  caused  by  a  drug.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1119991073
ER  -